TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25122038

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg, over 40 min)
Number of subjects: 16
Study: 23822578

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor‐based triple therapy
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: H. pylori-negative group (after eradication)
Number of subjects: 190

Group type: COMPARATOR
Intervention: H. pylori-positive group (persistent infection)
Number of subjects: 190
Study: 21373300

Group type: EXPERIMENTAL
Intervention: Fascia-iliaca block with bupivacaine and parenteral saline injection (Group A)
Number of subjects: 154

Group type: COMPARATOR
Intervention: IV NSAID injection with fascia-iliaca block (Group B)
Number of subjects: 154
Study: 18422393

Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel (dual antiplatelet therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel pretreatment prior to PCI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance to aspirin and clopidogrel
Number of subjects: 0
Study: 16634993

Group type: EXPERIMENTAL
Intervention: Glucerna SR 323 ml
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ensure high calcium 315 ml
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose 75 g
Number of subjects: 14
Study: 14516896

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine infusion
Number of subjects: 24
Study: 10854861

Group type: EXPERIMENTAL
Intervention: LMWH (enoxaparin sodium, 40 mg daily) + low-dose aspirin (100 mg daily) in the first trimester (group 1, n=14)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: LMWH (enoxaparin sodium, 40 mg daily) + low-dose aspirin (100 mg daily) in the second trimester (group 2, n=17)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low-dose aspirin alone (group 3, n=15)
Number of subjects: 46
Study: 9190135

Group type: EXPERIMENTAL
Intervention: Anti-reflection coated lenses
Number of subjects: 46

Group type: COMPARATOR
Intervention: Uncoated lenses
Number of subjects: 46
Study: 8227478

Group type: EXPERIMENTAL
Intervention: 24 mg methylprednisolone (Medrol Tablets)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 6 mg methylprednisolone (Medrol Tablets)
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0 mg methylprednisolone (placebo)
Number of subjects: 31
Study: 3541502

Group type: EXPERIMENTAL
Intervention: 0.2 mg levothyroxine daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Routine thyroxine treatment
Number of subjects: 29
Study: 31350962

Group type: EXPERIMENTAL
Intervention: Gonadotropin, GnRH antagonist, and GH from the eighth day of the cycle for about 5 days (n = 34)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Gonadotropin, GnRH antagonist, and GH from the third day of the previous cycle for about 20 days (n = 32)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Gonadotropin, GnRH antagonist, and placebo from the eighth day of the cycle for about 5 days (n = 26)
Number of subjects: 92
Study: 30337309

Group type: COMPARATOR
Intervention: Nurse support (12-week walking programmes and PA diaries delivered by post or through three PA consultations with practice nurses)
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Postal group (pedometer intervention delivered by post)
Number of subjects: 1023
Study: 26933848

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg preoperatively)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2100
Study: 24238651

Group type: EXPERIMENTAL
Intervention: Mobile Bearing (MB) prosthesis
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fixed Bearing (FB) prosthesis
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (age and gender matched)
Number of subjects: 16
Study: 22545014

Group type: EXPERIMENTAL
Intervention: Polymerized collagen (2 mL, 6 intraarticular injections over 3 months)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (2 mL, 6 intraarticular injections over 3 months)
Number of subjects: 19
Study: 20682030

Group type: EXPERIMENTAL
Intervention: Singing classes (6-week course, twice weekly)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 18242412

Group type: EXPERIMENTAL
Intervention: ACCP-recommended VTE prophylaxis for surgical patients at risk
Number of subjects: 68183

Group type: COMPARATOR
Intervention: ACCP-recommended VTE prophylaxis for medical patients at risk
Number of subjects: 68183

Group type: EXPERIMENTAL
Intervention: Patients at risk for VTE
Number of subjects: 68183

Group type: EXPERIMENTAL
Intervention: Surgical patients at risk for VTE
Number of subjects: 68183

Group type: EXPERIMENTAL
Intervention: Medical patients at risk for VTE
Number of subjects: 68183
Study: 15901862

Group type: EXPERIMENTAL
Intervention: Training traditional birth attendants and providing disposable delivery kits; integration with Lady Health Workers and obstetrical teams for antenatal care.
Number of subjects: 20157

Group type: COMPARATOR
Intervention: Usual care provided in control talukas.
Number of subjects: 20157
Study: 12873240

Group type: EXPERIMENTAL
Intervention: Alcohol reduction motivational interview (MI)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Information pack (IP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Matched controls (not receiving MI or IP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined MI-IP group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dependent and harmful consumers (AUDIT classifications)
Number of subjects: 120
Study: 10570373

Group type: EXPERIMENTAL
Intervention: Photopheresis for 1 year
Number of subjects: 19

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Photopheresis after crossover
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Immunologic parameters
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 19
Study: 8877596

Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1577045

Group type: EXPERIMENTAL
Intervention: Gallopamil 100 mg b.i.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gallopamil 100 mg o.d.
Number of subjects: 20
Study: 4063326

Group type: EXPERIMENTAL
Intervention: 20-50 g Palatinit/d
Number of subjects: 11
Study: 31733785

Group type: EXPERIMENTAL
Intervention: Lumbosacral orthosis (LSO) with routine physical therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine physical therapy alone
Number of subjects: 44
Study: 30672179

Group type: EXPERIMENTAL
Intervention: Conventional combined with magnetotherapy group (observation 1)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Conventional combined with vaccaria seed group (observation 2)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional group (control)
Number of subjects: 93
Study: 26142227

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation (LC) in APROP (Group 1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation (LC) in TD (Group 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No laser photocoagulation (Group 3)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Full-term children (Group 4)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Groups 1 and 2
Number of subjects: 75

Group type: COMPARATOR
Intervention: Groups 3 and 4
Number of subjects: 75

Group type: COMPARATOR
Intervention: Groups 2 and 3
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Groups 1-4
Number of subjects: 75
Study: 25303111

Group type: EXPERIMENTAL
Intervention: Psycho-education intervention by midwives, including telephone counseling at 24 and 34 weeks of pregnancy.
Number of subjects: 170

Group type: COMPARATOR
Intervention: Usual care offered by public maternity services (Control group).
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Psycho-education intervention by midwives.
Number of subjects: 170
Study: 22701683

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 20146902

Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation with no telephone follow‐up
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation with telephone follow‐up
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Community rehabilitation with no telephone follow‐up
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Community rehabilitation with telephone follow‐up
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 240

Group type: COMPARATOR
Intervention: No telephone follow-up
Number of subjects: 240
Study: 17666307

Group type: EXPERIMENTAL
Intervention: Knee sleeve (neoprene sleeve)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No knee sleeve
Number of subjects: 50
Study: 16193773

Group type: EXPERIMENTAL
Intervention: New 25-dimensional feature space
Number of subjects: 56

Group type: COMPARATOR
Intervention: Previous 19-dimensional feature space
Number of subjects: 56

Group type: COMPARATOR
Intervention: Combined 44-dimensional feature space
Number of subjects: 56
Study: 12207067

Group type: EXPERIMENTAL
Intervention: Aboral pouch with preserved duodenal passage
Number of subjects: 17
Study: 10520146

Group type: EXPERIMENTAL
Intervention: True occlusal adjustment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mock adjustment
Number of subjects: 40
Study: 8541200

Group type: EXPERIMENTAL
Intervention: Dopexamine hydrochloride at a rate of 2 micrograms/kg/min (n = 15)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.9% saline solution as placebo (n = 17)
Number of subjects: 32
Study: 1791015

Group type: EXPERIMENTAL
Intervention: Sustained Release (SR) Theophylline plus Hydroxyethyltheophylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Theophylline plus Hydroxyethyltheophylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aminophylline Tablets
Number of subjects: 0
Study: 7037758

Group type: EXPERIMENTAL
Intervention: Viloxazine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 20
Study: 30931667

Group type: EXPERIMENTAL
Intervention: Resurfacing hip arthroplasty (RHA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Total hip arthroplasty (THA)
Number of subjects: 34
Study: 29479726

Group type: EXPERIMENTAL
Intervention: Secondary prevention programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 27781255

Group type: EXPERIMENTAL
Intervention: Less than 3 months treatment group
Number of subjects: 35

Group type: COMPARATOR
Intervention: More than 3 months treatment group
Number of subjects: 35
Study: 24859422

Group type: EXPERIMENTAL
Intervention: Dorsolateral pre-frontal cortex (DLPFC) stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Posterior parietal cortex (PPC) stimulation
Number of subjects: 20
Study: 22617278

Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition (IN)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Isocaloric‐isonitrogenous nutrition (ICN)
Number of subjects: 152
Study: 21171981

Group type: EXPERIMENTAL
Intervention: Brief intervention in passive smoking after specific training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Habitual care (Control)
Number of subjects: 0
Study: 18065143

Group type: EXPERIMENTAL
Intervention: Interferon 1-b injections
Number of subjects: 0
Study: 15741226

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b (IFN-alpha-2b)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No maintenance therapy (control)
Number of subjects: 90
Study: 11997800

Group type: EXPERIMENTAL
Intervention: RetCam 120 images acquired by a neonatal nurse at examination 1 (32 to 34 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: RetCam 120 images acquired by a neonatal nurse at examination 2 (38 to 40 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Examination by an experienced ophthalmologist (control)
Number of subjects: 46
Study: 9529260

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen for 15 minutes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Breathing room air for 15 minutes
Number of subjects: 14
Study: 8746390

Group type: EXPERIMENTAL
Intervention: Non-drug treatments
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Drugs (general)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Benzodiazepines, antidepressants, and other substances
Number of subjects: 159
Study: 2534464

Group type: EXPERIMENTAL
Intervention: Manual stimulation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Electrical stimulation at 2 Hz
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Electrical stimulation at 80 Hz
Number of subjects: 6

Group type: COMPARATOR
Intervention: Superficial-acupuncture (placebo)
Number of subjects: 6
Study: 761539

Group type: EXPERIMENTAL
Intervention: Proglumide (1200 mg daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Magnesium tricilicate (1320 mg daily, active placebo)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Proglumide
Number of subjects: 51
Study: 30040011

Group type: EXPERIMENTAL
Intervention: Maitland grade III mobilization
Number of subjects: 48

Group type: COMPARATOR
Intervention: Maitland grade I mobilization
Number of subjects: 48
Study: 28619300

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Spinal Orthopedic Manipulation (TCSOM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pinaverium Bromide (PBD)
Number of subjects: 60
Study: 24797706

Group type: EXPERIMENTAL
Intervention: Online intervention to improve gluten-free diet adherence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early intervention modules
Number of subjects: 0
Study: 23835688

Group type: EXPERIMENTAL
Intervention: Soy germ pasta
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional pasta
Number of subjects: 10
Study: 21942655

Group type: EXPERIMENTAL
Intervention: DHEA 10 mg daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: HRT (1 mg estradiol + 5 mg dihydrogesterone)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: DHEA, HRT, and tibolone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vitamin D (400 IU)
Number of subjects: 48
Study: 19254400

Group type: EXPERIMENTAL
Intervention: Autologous fascial sling (AFS)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Quality of life assessment at 36 months
Number of subjects: 41
Study: 17661558

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4000 IU/day vitamin D
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups (2000 IU/day and 4000 IU/day)
Number of subjects: 25
Study: 15534514

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nonresurfacing of the patella
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 11295026

Group type: EXPERIMENTAL
Intervention: Preparation A (800 microg folic acid, 6 microg vitamin B12, 10 mg vitamin B6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preparation B (160 microg folic acid, no vitamin B12, 10 mg vitamin B6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9399608

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 246 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 7703633

Group type: EXPERIMENTAL
Intervention: TCM-WM therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 0
Study: 3063832

Group type: EXPERIMENTAL
Intervention: Aspiration of middle ear effusions prior to ventilation tube insertion
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-aspirated middle ear
Number of subjects: 55
Study: 29672567

Group type: EXPERIMENTAL
Intervention: Pharmacist-led group medical visits
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 250
Study: 26887645

Group type: EXPERIMENTAL
Intervention: TESSYS
Number of subjects: 106

Group type: COMPARATOR
Intervention: FD
Number of subjects: 106
Study: 25636669

Group type: EXPERIMENTAL
Intervention: Bilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Unilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Number of subjects: 14
Study: 23889978

Group type: EXPERIMENTAL
Intervention: Assisted reflection on life events and ultimate life goals using a brief structured interview scheme supported by an e-application (two consultations with a spiritual counsellor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 0
Study: 19900212

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 326

Group type: COMPARATOR
Intervention: Non-prostaglandin therapy (non-PGs)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Latanoprost and Non-prostaglandin therapy (non-PGs)
Number of subjects: 326
Study: 18213621

Group type: EXPERIMENTAL
Intervention: Concomitant and adjuvant temozolomide (TMZ)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Initial radiotherapy alone
Number of subjects: 219
Study: 16996288

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 9
Study: 15019894

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg once daily for 3 weeks before and 6 weeks after electrical cardioversion
Number of subjects: 114

Group type: COMPARATOR
Intervention: No drug in addition to standard therapy
Number of subjects: 114
Study: 11705559

Group type: EXPERIMENTAL
Intervention: MaxSTE (ST-segment deviation in the single ECG lead with maximum deviation)
Number of subjects: 2719

Group type: EXPERIMENTAL
Intervention: SumSTR (sum of early resolution of ST-segment elevation)
Number of subjects: 2719
Study: 9057509

Group type: EXPERIMENTAL
Intervention: Multishot echoplanar MR imaging (EPI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fast spin-echo MR imaging
Number of subjects: 26
Study: 8221559

Group type: COMPARATOR
Intervention: Cisplatin-epidoxorubicin-cyclophosphamide (CEP) chemotherapy alone
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Cisplatin-epidoxorubicin-cyclophosphamide (CEP) plus recombinant alpha-2-IFN
Number of subjects: 182
Study: 3476650

Group type: EXPERIMENTAL
Intervention: Diphenhydramine hydrochloride with epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine with epinephrine
Number of subjects: 0
Study: 31569155

Group type: EXPERIMENTAL
Intervention: Endocrine-disrupting chemicals (EDCs)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Persistent EDCs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nonpersistent EDCs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Five persistent chemicals
Number of subjects: 50
Study: 29425398

Group type: EXPERIMENTAL
Intervention: Parent Management Training‐Oregon Model (PMTO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Child therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice group
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-choice group
Number of subjects: 0
Study: 27891568

Group type: EXPERIMENTAL
Intervention: Structured text message giving reassurance
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Structured telephone call
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no post-procedure communication)
Number of subjects: 84
Study: 24749354

Group type: EXPERIMENTAL
Intervention: Domestically produced Salbutamol Sulfate Aerosol MDI (200 microg single-dose)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Imported Salbutamol Sulfate Aerosol MDI (200 microg single-dose)
Number of subjects: 238
Study: 23194103

Group type: EXPERIMENTAL
Intervention: In-home health consultation program (HCP) with four in-home visits and three phone calls from APNs
Number of subjects: 461
Study: 19164490

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 21
Study: 18583000

Group type: EXPERIMENTAL
Intervention: Physician peer educator intervention during VFC visit
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physician peer educator intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: VFC visits
Number of subjects: 73
Study: 15966702

Group type: EXPERIMENTAL
Intervention: Buccal bioadhesive nystatin tablet (100,000 IU per tablet) applied daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional local cleaning with oral nystatin suspension on a brush
Number of subjects: 19

Group type: COMPARATOR
Intervention: No antimicrobial agents (Control group)
Number of subjects: 19
Study: 12366489

Group type: EXPERIMENTAL
Intervention: Total abdominal hysterectomy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Total and subtotal abdominal hysterectomy
Number of subjects: 30
Study: 9445494

Group type: EXPERIMENTAL
Intervention: Stavudine (d4T) 1 mg/kg orally every 12 hours, maximum 40 mg orally every 12 hours
Number of subjects: 212

Group type: COMPARATOR
Intervention: Zidovudine (ZDV, AZT) 180 mg/m2 orally every 6 hours, maximum 200 mg orally every 6 hours
Number of subjects: 212
Study: 7599909

Group type: EXPERIMENTAL
Intervention: Dipyrone (1 g, 3 times/day for 2 days, followed by twice 1 g on day 3)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg, 3 times/day for 2 days, followed by twice 50 mg on day 3)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2369315

Group type: EXPERIMENTAL
Intervention: Fluorouracil therapy (500 mg/m2 per day) by portal vein infusion for 7 days
Number of subjects: 224

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Fluorouracil therapy
Number of subjects: 224